© Globe Newswire
10.01.2026
FHTX
LISTED
NASDAQ
Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026
News Preview
Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a leading biotech mutual fund in a transaction that will close January 13th, 2026...
Themefolio
Profiler
Peergroup
© BusinessWire
10.01.2026
SMMT
LISTED
NASDAQ
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 214,331 shares of common stock. Awards were made to seventeen new employees of the Company. The awards were granted as an inducement material to the new employees becoming empl...
Themefolio
Profiler
Peergroup
© Newsfile
10.01.2026
NTHI
LISTED
NASDAQ
Stonegate Capital Partners Initiates Coverage on NeOnc Technologies Holdings, Inc. (NTHI)
News Preview
Dallas, Texas--(Newsfile Corp. - January 9, 2026) - NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI). Stonegate Capital Partners initiates their coverage on NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI). NeOnc Technologies Holdings, Inc. is a clinical-stage life sciences company developing central nervous system therapeutics designed to ove...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
10.01.2026
EW
LISTED
NYSE
Edwards Comments on JenaValve Acquisition
News Preview
Edwards Lifesciences (NYSE: EW) today announced that the U.S. District Court for the District of Columbia has granted the motion from the U.S. Federal Trade Commission (FTC) for an injunction blocking the company’s proposed acquisition of JenaValve Technology. As a result, Edwards will not acquire JenaValve.
Edwards disagrees with the decision a...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
09.01.2026
SKYE
LISTED
NASDAQ
SKYE Deadline: Rosen Law Firm Urges Skye Bioscience, Inc. (NASDAQ: SKYE) Stockholders to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Skye Bioscience, Inc. (NASDAQ: SKYE) between November 4, 2024 and October 3, 2025. Skye is a clinical stage biopharmaceutical company.
For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653.
The Allegations: Rosen...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
ASND
LISTED
NASDAQ
Ascendis Pharma Provides Business and Strategic Roadmap Update at 44th Annual J.P. Morgan Healthcare Conference
News Preview
- Rapidly transforming into a leading global biopharma company - Rapidly transforming into a leading global biopharma company...
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2026
MTD
LISTED
NYSE
Mettler-Toledo International Inc. to Host Fourth Quarter 2025 Earnings Conference Call
News Preview
Mettler-Toledo International Inc. (NYSE: MTD) announced it will release its fourth quarter 2025 financial results after the market close on Thursday, February 5, 2026. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Pre...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
HYTN
LISTED
CSE
HYTN Announces Engagement of Marketing and Communications Services Provider
News Preview
VANCOUVER, British Columbia, Jan. 09, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in cannabis, announces that it has engaged MCS Market Communication Service GmbH (“MCS”) to provide certain marketing and communications services....
Themefolio
Profiler
Peergroup
© PR Newswire
09.01.2026
TLT
LISTED
TSX
Canadian Investment Regulatory Organization Trading Halt - TLT
News Preview
VANCOUVER, BC, Jan. 9, 2026 /CNW/ - The following issues have been halted by CIRO
Company: Theralase Technologies Inc.TSX-Venture Symbol: TLT All Issues: YesReason: Pending News Halt Time (ET): 3:45 PMCIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemente...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
FULC
LISTED
NASDAQ
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
CAMBRIDGE, Mass., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to three new employees. Fulcr...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
ALMS
LISTED
NASDAQ
Alumis Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
News Preview
Alumis Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
PRAX
LISTED
NASDAQ
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that on January 2, 2026, the Comp...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
09.01.2026
SXTC
LISTED
NASDAQ
China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering
News Preview
TAIZHOU, China, Jan. 09, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) (the “Company”), today announced that it has entered into a definitive agreement with a single investor for the purchase and sale of an aggregate of 66,666,666 Class A ordinary shares of the company, no par value per share (the “Shares”) (or pre-fund...
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2026
ASRT
LISTED
NASDAQ
Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial
News Preview
Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that results of a clinical trial investigating a novel dosing schedule of Rolvedon® (eflapegrastim-xnst) injection have been peer reviewed and published in The Oncologist.
In the study of patients with early-stage breast cancer (ESBC), Rolvedon, when administere...
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2026
IDXX
LISTED
NASDAQ
IDEXX Laboratories to Release 2025 Fourth Quarter and Full Year Financial Results
News Preview
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 fourth quarter and full year financial results for Monday, February 2, 2026, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Individuals can access a live...
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2026
DNTL
LISTED
TSX
Dentalcorp Announces Receipt of Investment Canada Act Approval and Expected Closing Date for Acquisition by Investment Funds Affiliated with GTCR
News Preview
dentalcorp Holdings Ltd. (“Dentalcorp” or the “Company”) (TSX: DNTL) announced today that the Company has received approval under the Investment Canada Act for its previously-announced plan of arrangement whereby a newly formed acquisition vehicle controlled by GTCR LLC (“GTCR”) will acquire all of Dentalcorp’s issued and outstanding subordinate v...
Themefolio
Profiler
Peergroup
© PR Newswire
09.01.2026
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Transaction in Own Shares
News Preview
For immediate release
9 January 2026
WORLDWIDE HEALTHCARE TRUST PLC
(the "Company")
...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
VERA
LISTED
NASDAQ
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Vera Therapeutics announces inducement grants under Nasdaq Listing Rule 5635(c)(4)....
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2026
AQST
LISTED
NASDAQ
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Aquestive Therapeutics, Inc. (“Aquestive” or the “Company”) (NASDAQ: AQST).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260109769684/en/
Faruqi & Faruqi is a leading natio...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
VIRP
LISTED
EURONEXT
Virbac : Declaration of the number of shares and voting rights 12/2025
News Preview
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
DRUG
LISTED
NASDAQ
Bright Minds Biosciences Announces Closing of US$175 Million Public Offering
News Preview
NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”) today closed its recently announced public offering of 1,945,000 common shares in the capital of the Company (the “Common Shares”) at a price of US$90.00 per Common Share for gross proceeds of US$175,050,000 (the...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
FAGR
LISTED
EURONEXT
Disclosure of notification received from BNP Paribas
News Preview
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 09 January 2026 – 5:40 PM CET...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
09.01.2026
AVNT
LISTED
TSX
Avant Brands Adopts Shareholder Rights Plan
News Preview
KELOWNA, BC / ACCESS Newswire / January 9, 2026 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products, announces that its board of directors (the "Board") has approved the adoption of a shareholder rights plan (the "Sh...
Themefolio
Profiler
Peergroup
© ActuNews
09.01.2026
BOI
LISTED
EURONEXT
BOIRON : Déclaration des droits de vote au 31 décembre 2025
News Preview
Le 9 janvier 2026
Publication
du nombre d'actions composant le capital et du nombre total de droits de vote
(articles L. 233-8 II du code de commerce et 223-16 du règlement général de l'AMF)
Date d'arrêt des informations
Nombre total d'actions composant le capital
Nombre total de droits de...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
FTRE
LISTED
NASDAQ
Fortrea Announces Updated Presentation Time at Upcoming J.P. Morgan Healthcare Conference
News Preview
DURHAM, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced an updated presentation time of 11:15 am PST on Tuesday, January 13, 2026, at the J.P. Morgan Annual Healthcare Conference (San Francisco)....
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2026
TLX
LISTED
NASDAQ
FINAL DEADLINE ALERT: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Telix Pharmaceuticals Limited (“Telix” or the “Company”) (NASDAQ: TLX) and reminds investors of the January 9, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Th...
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2026
CORT
LISTED
NASDAQ
Scott+Scott Attorneys at Law LLP Reminds Investors of Its Investigation Into Corcept Therapeutics Incorporated (NASDAQ: CORT)
News Preview
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ: CORT) or certain of its officers and directors issued misleading and false statements and/or failed to disclose information material to investors in vi...
Themefolio
Profiler
Peergroup
© PR Newswire
09.01.2026
CAMX
LISTED
STO
Camurus announces FDA acceptance of NDA resubmission for Oclaiz™ for the treatment of acromegaly
News Preview
PDUFA target action date set to 10 June 2026 LUND, Sweden, Jan. 9, 2026 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's resubmission of the New Drug Application (NDA) for Oclaiz™ (CAM2029), octreotide extended-release injection, for the treatment of p...
Themefolio
Profiler
Peergroup
© PR Newswire
09.01.2026
CAMX
LISTED
STO
Camurus announces FDA acceptance of NDA resubmission for Oclaiz™ for the treatment of acromegaly
News Preview
PDUFA target action date set to 10 June 2026 LUND, Sweden, Jan. 9, 2026 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's resubmission of the New Drug Application (NDA) for Oclaiz™ (CAM2029), octreotide extended-release injection, for the treatment of p...
Themefolio
Profiler
Peergroup
© PR Newswire
09.01.2026
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC
LEI: 5493003YBCY4W1IMJU04
NET ASSET VALUE
The estimated un-audited net asset val...
Themefolio
Profiler
Peergroup
© PR Newswire
09.01.2026
CVS
LISTED
NYSE
CVS Health to hold fourth quarter and full year 2025 earnings conference call
News Preview
WOONSOCKET, R.I., Jan. 9, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, February 11th, 2026, at 8:00 a.m. ET to discuss fourth quarter and full year 2025 financial results....
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2026
EOLS
LISTED
NASDAQ
Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Net Revenue
News Preview
Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio, today announced its preliminary, unaudited net revenue for the fourth quarter and full-year ended December 31, 2025. The preliminary unaudited results described in this press release are based on the most current information available...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
HRTX
LISTED
NASDAQ
Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net Revenue; ZYNRELEF® Largest Contributor to Q4 Growth
News Preview
CARY, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or the “Company”), a commercial-stage biotechnology company, today announced preliminary, unaudited fourth quarter and full-year 2025 net revenue....
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
SIA
LISTED
TSX
Sienna Announces Fourth Quarter 2025 Results Release Date and Conference Call
News Preview
MARKHAM, Ontario, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) announced that it will report its 2025 fourth quarter results after market close on Thursday, February 19, 2026. Nitin Jain, President and Chief Executive Officer, and David Hung, Chief Financial Officer and Executive Vice Presiden...
Themefolio
Profiler
Peergroup
© PR Newswire
09.01.2026
RIGL
LISTED
NASDAQ
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
News Preview
SOUTH SAN FRANCISCO, Calif., Jan. 9, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL) today announced that it has granted awards pursuant to the Rigel Pharmaceuticals, Inc. Inducement Plan, approved by the Compensation Committee of Rigel's Board of Directors and granted as an inducement material to employees entering into...
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2026
DCTH
LISTED
NASDAQ
Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
News Preview
Delcath Systems, Inc. (Nasdaq: DCTH) (“Delcath” or the “Company”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced preliminary financial results and business updates for the fourth quarter and year-ended December 31, 2025.
Preliminary Fourth Quarter and Full-Year 2025 Fi...
Themefolio
Profiler
Peergroup
© PR Newswire
09.01.2026
EHC
LISTED
NYSE
Encompass Health announces date of 2025 fourth quarter earnings call
News Preview
BIRMINGHAM, Ala., Jan. 9, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its fourth quarter ended Dec. 31, 2025, after the market closes on Thursday, Feb. 5, 2026. The Company will host an investor conference call at 10 a.m. ET on Friday, Feb. 6, 2026, to discuss its results....
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
CLTX
LISTED
NASDAQ
Akari Therapeutics Releases New CEO Corner Segment Highlighting 2025 Progress and Path to Clinical Transition In 2026
News Preview
Access the Akari CEO Corner here...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS9 January 2026 at 16:00 EET ...
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2026
RVTY
LISTED
NYSE
Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models
News Preview
Revvity, Inc. (NYSE: RVTY) today announced a collaboration with Eli Lilly and Company (Lilly) that expands access to Lilly’s high-quality predictive models by making Lilly TuneLab available through the Revvity Signals platform. The collaboration builds on Revvity’s recently introduced Signals XyntheticaTM offering, creating a scalable, federated f...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
RPRX
LISTED
NASDAQ
Royalty Pharma Announces Dividend Increase
News Preview
NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that its board of directors has declared a dividend for the first quarter of 2026 of $0.235 per Class A ordinary share, reflecting a 6.8% increase in the company’s quarterly dividend over the previous quarter’s dividend....
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
LXRX
LISTED
NASDAQ
Lexicon Pharmaceuticals Publishes “Relief is Possible: Ensuring Access to Effective Treatments for Chronic Pain”
News Preview
-White Paper based on October 2025 Roundtable of diverse stakeholders focused on accelerating innovation and expanding access to novel non-opioid therapies-...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
CRMD
LISTED
NASDAQ
CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
BERKELEY HEIGHTS, N.J., Jan. 09, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that Joseph Todisco, Chairman and CEO of CorMedix Therapeutics, will present a corporate overview a...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
TNYA
LISTED
NASDAQ
Tenaya Therapeutics Announces 2026 Strategic Priorities and Anticipated Milestones
News Preview
Aims to Build on Positive 2025 Interim TN-201 Results in First Half of 2026 with Longer-Term Follow-Up Data for Cohorts 1 and 2 from MyPEAK™-1 Trial of Adults with MYBPC3-Associated HCM...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
CGON
LISTED
NASDAQ
CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC
News Preview
- PIVOT-006 Phase 3 topline data evaluating cretostimogene monotherapy for intermediate-risk NMIBC now expected in 1H 2026, nearly one year ahead of schedule...
Themefolio
Profiler
Peergroup
© EQS Newswire
09.01.2026
SKNY
LISTED
CSE
LIR Life startet nächste Entwicklungsphase – Setzt die neue Partnerschaft weitere positive Impulse für den Kursverlauf?
News Preview
EQS-Media / 09.01.2026 / 13:10 CET/CEST
Lir Life Sciences Corp. (ISIN: CA50206C1005 | WKN: A41QA9), LIR oder das Unternehmen, freut sich bekannt zu geben, dass das Unternehmen eine Dienstleistungsvereinbarung (F&E-Vereinbarung) mit “Neuland Laboratories Limited” (“Neuland Labs”), einer globalen Auftragsentwicklungs- und Auftragsherstellung......
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
CLRB
LISTED
NASDAQ
Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference
News Preview
Following Guidance from the European Medicines Agency’s (EMA) Scientific Advice Working Party (SAWP) Regarding Iopofosine I 131 for the Treatment of Waldenstrom’s Macroglobulinemia (WM), Expects to Submit for Conditional Marketing Approval in Europe in 3Q 2026...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
SELB
LISTED
NASDAQ
Cartesian Therapeutics Highlights Recent Progress and Outlines 2026 Outlook
News Preview
Enrollment on track in Phase 3 AURORA trial of Descartes-08 in myasthenia gravis ...
Themefolio
Profiler
Peergroup
© PR Newswire
09.01.2026
INSM
LISTED
NASDAQ
Insmed Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference
News Preview
— BRINSUPRI® (brensocatib) Unaudited Total Revenues of Approximately $144.6 Million for First Full Quarter of Launch; Approximately $172.7 Million for Full-Year 2025——ARIKAYCE® (amikacin liposome inhalation suspension) Exceeds the Upper End of Guidance Range for Full-Year 2025 with Unaudited Global Revenues of Approximately $433.8 Million——Full-Ye...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
AZYO
LISTED
NASDAQ
Elutia to Present at Global BioInnovation Forum on NXT-41x Biomatrix Program for Plastic and Reconstructive Surgery
News Preview
Company to present Tuesday, January 13th at 10:00 a.m. PT / 1:00 p.m. ET...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
NAMS
LISTED
NASDAQ
NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities
News Preview
-- EMA approval decision for obicetrapib and obicetrapib/ezetimibe fixed dose combo expected in 2H26 -- -- Phase 3 PREVAIL CVOT overall event rate tracking in line with observed rate in BROADWAY --...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
MDGL
LISTED
NASDAQ
Madrigal Expands its MASH Pipeline with Exclusive Global License Agreement for Ervogastat, a Phase 2 Oral DGAT-2 Inhibitor
News Preview
CONSHOHOCKEN, Pa., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced an exclusive global license agreement with Pfizer for ervogastat, a clinical-stage oral DGAT-2 inhibit...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
TOI
LISTED
NASDAQ
The Oncology Institute Announces Leadership Promotions
News Preview
Rakesh Panda appointed Chief Information Officer...
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2026
PLSE
LISTED
NASDAQ
Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors
News Preview
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced the appointment of Maria Sainz to its Board of Directors effective as of January 9, 2026.
“We are delighted to welcome Maria to our Board of Directors...
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2026
SDGR
LISTED
NASDAQ
Schrödinger Partners with Lilly to Make TuneLab Platform Available in LiveDesign
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today announced a collaboration with Lilly TuneLab™, a platform launched by Eli Lilly and Company (Lilly) designed to accelerate drug discovery and development by providing access to advanced artificial intelligence (AI) capabilities. TuneLab will be made available in LiveDesign, Schrödinger’s widely used enterpris...
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2026
BRKR
LISTED
NASDAQ
Bruker Announces $500 Million in Multi-Year Orders from Two Global Healthcare Companies for Supply of High-Performance Superconductors for MRI
News Preview
The Bruker Energy & Supercon Technologies (BEST) division, a segment of Bruker Corporation (Nasdaq: BRKR), today announced two multi-year supply agreements for Bruker’s latest superconductors, which are used by global radiology companies to build their next generations of magnetic resonance imaging (MRI) magnets.
This press release features m...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
TECN
LISTED
SIX
Tecan to present at upcoming Investor Conferences
News Preview
Männedorf, Switzerland, January 9, 2026 – The Tecan Group (SIX Swiss Exchange: TECN) today announced that it will attend and present at the following investor conferences in the upcoming week:...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
PVLA
LISTED
NASDAQ
Palvella Therapeutics Provides Corporate Update and 2026 Outlook: Advancing a Late Clinical-Stage Pipeline and Platform to Address Multiple Serious, Rare Skin Diseases and Vascular Malformations with No FDA-Approved Therapies
News Preview
Phase 3 SELVA study evaluating QTORIN™ rapamycin 3.9% anhydrous gel (QTORIN™ rapamycin) for microcystic lymphatic malformations (microcystic LMs) remains on track, with topline results anticipated in March 2026; pending positive results, an NDA submission is planned for the second half of 2026...
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2026
HUM
LISTED
NYSE
Humana Inc. to Release Fourth Quarter 2025 Results on February 11, 2026
News Preview
Humana Inc. (NYSE: HUM) will release its financial results for the fourth quarter 2025 (4Q25), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on February 11, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and e...
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2026
CL
LISTED
CSE
Cresco Labs Opens Sunnyside Tamarac, Expanding Patient Access in Broward County, Florida
News Preview
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the grand opening of Sunnyside Tamarac, located at 6001 N University Drive in Tamarac, Fla. It is the Company’s 31st dispensary in Florida and 72nd nationwide.
This press release features multimedia. View the full release here: https://www.busin...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
